{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T02:01:13Z","timestamp":1772244073904,"version":"3.50.1"},"reference-count":63,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2014.0877","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T05:19:26Z","timestamp":1525238366000},"source":"Crossref","is-referenced-by-count":15,"title":["The Conservative and Interventional Treatment of Fibroids"],"prefix":"10.3238","author":[{"given":"Alexander Stephan","family":"Boosz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Reimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Matzko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"R\u00f6mer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11437","published-online":{"date-parts":[[2014,12,22]]},"reference":[{"key":"10.3238\/arztebl.2014.0877_ref1","doi-asserted-by":"crossref","unstructured":"Ciavattini A, Di Giuseppe J, Stortoni P, et al.: Uterine fibroids: pathogenesis and interactions with endometrium and endomyometrial junction. Obstet Gynecol Int 2013; 173\u201384.","DOI":"10.1155\/2013\/173184"},{"key":"10.3238\/arztebl.2014.0877_ref2","doi-asserted-by":"crossref","unstructured":"Zimmermann A, Bernuit D, Gerlinger C, Schaefers M, Geppert K: Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women. BMC Womens Health 2012; 12: 6.","DOI":"10.1186\/1472-6874-12-6"},{"key":"10.3238\/arztebl.2014.0877_ref3","doi-asserted-by":"crossref","unstructured":"Donnez J, Jadoul P. What are the implications of myomas on fertility? A need for a debate? Hum Reprod 2002; 17: 1424\u201330.","DOI":"10.1093\/humrep\/17.6.1424"},{"key":"10.3238\/arztebl.2014.0877_ref4","doi-asserted-by":"crossref","unstructured":"Metwally M, Cheong YC, Horne AW: Surgical treatment of fibroids for subfertility: Cochrane Database Syst Rev 2012 Nov 14; 11: CD003857.","DOI":"10.1002\/14651858.CD003857.pub3"},{"key":"10.3238\/arztebl.2014.0877_ref5","doi-asserted-by":"crossref","unstructured":"Ciavattini A, Clemente N, Delli Carpini G, Di Giuseppe J, Giannubilo SR, Tranquilli AL: Number and size of uterine fibroids and obstetric outcomes. J Matern Fetal Neonatal Med 2014; 5: 1\u20135.","DOI":"10.3109\/14767058.2014.921675"},{"key":"10.3238\/arztebl.2014.0877_ref6","doi-asserted-by":"crossref","unstructured":"Shavell V, Thakur M, Sawant A, et al.: Adverse obstetric outcomes associated with sonographically identified large uterine fibroids. Fertil Steril 2012; 97: 107\u201310.","DOI":"10.1016\/j.fertnstert.2011.10.009"},{"key":"10.3238\/arztebl.2014.0877_ref7","doi-asserted-by":"crossref","unstructured":"Capmas P, Levaillant JM, Fernandez H: Surgical techniques and outcome in the management of submucous fibroids. Curr Opin Obstet Gynecol 2013; 25: 332\u20138.","DOI":"10.1097\/GCO.0b013e3283630e10"},{"key":"10.3238\/arztebl.2014.0877_ref8","doi-asserted-by":"crossref","unstructured":"Donnez J, Tomaszewski J, V\u00e1zquez F, et al. PEARL II Study Group. Ulipristal acetate versus leuprolide acetate for uterine fibroids. N Engl J Med 2012; 366: 421\u201332.","DOI":"10.1056\/NEJMoa1103180"},{"key":"10.3238\/arztebl.2014.0877_ref9","doi-asserted-by":"crossref","unstructured":"Manyonda IT, Bratby M, Horst JS, Banu N, Gorti M, Belli AM: Uterine artery embolization versus myomectomy: impact on quality of life\u2013results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) Trial. Cardiovasc Intervent Radiol 2012; 35: 530\u20136.","DOI":"10.1007\/s00270-011-0228-5"},{"key":"10.3238\/arztebl.2014.0877_ref10","doi-asserted-by":"crossref","unstructured":"van der Kooij SM, Hehenkamp WJ, Birnie E, et al.: The effect of treatment preference and treatment allocation on patients\u2019 health-related quality of life in the randomized EMMY trial. Eur J Obstet Gynecol Reprod Biol 2013; 169: 69\u201374.","DOI":"10.1016\/j.ejogrb.2013.01.019"},{"key":"10.3238\/arztebl.2014.0877_ref11","doi-asserted-by":"crossref","unstructured":"Sangkomkamhang US, Lumbiganon P, Laopaiboon M, Mol BW: Progestogens or progestogen-releasing intrauterine systems for uterine fibroids. Cochrane Database Syst Rev. 2013 Feb 28; 2: CD008994.","DOI":"10.1002\/14651858.CD008994.pub2"},{"key":"10.3238\/arztebl.2014.0877_ref12","doi-asserted-by":"crossref","unstructured":"Tristan M, Orozco LJ, Steed A, Ram\u00edrez-Morera A, Stone P: Mifepristone for uterine fibroids. Cochrane Database Syst Rev 2012; 8: CD007687.","DOI":"10.1002\/14651858.CD007687.pub2"},{"key":"10.3238\/arztebl.2014.0877_ref13","doi-asserted-by":"crossref","unstructured":"Ke LQ, Yang K, Li J, Li CM: Danazol for uterine fibroids. Cochrane Database Syst Rev 2009; 3: CD007692.","DOI":"10.1002\/14651858.CD007692"},{"key":"10.3238\/arztebl.2014.0877_ref14","doi-asserted-by":"crossref","unstructured":"Liu JP, Yang H, Xia Y, Cardini F: Herbal preparations for uterine fibroids. Cochrane Database Syst Rev 2013; 4: CD005292.","DOI":"10.1002\/14651858.CD005292.pub3"},{"key":"10.3238\/arztebl.2014.0877_ref15","doi-asserted-by":"crossref","unstructured":"Song H, Lu D, Navaratnam K, Shi G: Aromatase inhibitors for uterine fibroids. Cochrane Database Syst Rev 2013; 10: CD009505.","DOI":"10.1002\/14651858.CD009505.pub2"},{"key":"10.3238\/arztebl.2014.0877_ref16","doi-asserted-by":"crossref","unstructured":"Duhan N, Madaan S, Sen J: Role of the aromatase inhibitor letrozole in the management of uterine leiomyomas in premenopausal women. Eur J Obstet Gynecol Reprod Biol 2013; 171: 329\u201332.","DOI":"10.1016\/j.ejogrb.2013.09.010"},{"key":"10.3238\/arztebl.2014.0877_ref17","doi-asserted-by":"crossref","unstructured":"Mavrelos D, Ben-Nagi J, Davies A, Lee C, Salim R, Jurkovic D: The value of pre-operative treatment with GnRH analogues in women with submucous fibroids: a double-blind, placebo-controlled randomized trial. Hum Reprod 2010; 25: 2264\u20139.","DOI":"10.1093\/humrep\/deq188"},{"key":"10.3238\/arztebl.2014.0877_ref18","doi-asserted-by":"crossref","unstructured":"Donnez J, Tatarchuk TF, Bouchard P, et al.: PEARL I Study Group: Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med 2012; 366: 409\u201320.","DOI":"10.1056\/NEJMoa1103182"},{"key":"10.3238\/arztebl.2014.0877_ref19","doi-asserted-by":"crossref","unstructured":"Donnez J, V\u00e1zquez F, Tomaszewski J, et al.: Long-term treatment of uterine fibroids with ulipristal acetate. Fertil Steril 2014; 101: 1565\u201373, e1\u201318.","DOI":"10.1016\/j.fertnstert.2014.02.008"},{"key":"10.3238\/arztebl.2014.0877_ref20","doi-asserted-by":"crossref","unstructured":"Jin C, Hu Y, Chen XC, et al.: Laparoscopic versus open myomectomy\u2014a meta-analysis of randomized controlled trials. Eur J Obstet Gynecol Reprod Biol 2009; 145: 14\u201321.","DOI":"10.1016\/j.ejogrb.2009.03.009"},{"key":"10.3238\/arztebl.2014.0877_ref21","doi-asserted-by":"crossref","unstructured":"Sentilhes L, Vayssi\u00e8re C, Beucher G, et al.: Delivery for women with a previous cesarean: guidelines for clinical practice from the French College of Gynecologists and Obstetricians (CNGOF). Eur J Obstet Gynecol Reprod Biol 2013; 170: 25\u201332.","DOI":"10.1016\/j.ejogrb.2013.05.015"},{"key":"10.3238\/arztebl.2014.0877_ref22","doi-asserted-by":"crossref","unstructured":"Kim MS, Uhm YK, Kim JY, Jee BC, Kim YB: Obstetric outcomes after uterine myomectomy: Laparoscopic versus laparotomic approach. Obstet Gynecol Sci 2013; 56: 375\u201381.","DOI":"10.5468\/ogs.2013.56.6.375"},{"key":"10.3238\/arztebl.2014.0877_ref23","doi-asserted-by":"crossref","unstructured":"Bernardi TS, Radosa MP, Weisheit A, et al.: Laparoscopic myomectomy: a 6-year follow-up single-center cohort analysis of fertility and obstetric outcome measures. Arch Gynecol Obstet 2014; 290: 87\u201391.","DOI":"10.1007\/s00404-014-3155-2"},{"key":"10.3238\/arztebl.2014.0877_ref24","doi-asserted-by":"crossref","unstructured":"Mueller A, Boosz A, Koch M, et al.: The Hohl instrument for optimizing total laparoscopic hysterectomy: results of more than 500 procedures in a university training center. Arch Gynecol Obstet 2012; 285: 123\u20137.","DOI":"10.1007\/s00404-011-1905-y"},{"key":"10.3238\/arztebl.2014.0877_ref25","doi-asserted-by":"crossref","unstructured":"Lethaby A, Mukhopadhyay A, Naik R: Total versus subtotal hysterectomy for benign gynaecological conditions. Cochrane Database Syst Rev 2012; 4: CD004993.","DOI":"10.1002\/14651858.CD004993.pub3"},{"key":"10.3238\/arztebl.2014.0877_ref26","doi-asserted-by":"crossref","unstructured":"Boosz A, Lermann J, Mehlhorn G, et al.: Comparison of re-operation rates and complication rates after total laparoscopic hysterectomy (TLH) and laparoscopy-assisted supracervical hysterectomy (LASH); Eur J Obstet Gynecol Reprod Biol 2011; 158: 269\u201373.","DOI":"10.1016\/j.ejogrb.2011.04.021"},{"key":"10.3238\/arztebl.2014.0877_ref27","doi-asserted-by":"crossref","unstructured":"Nieboer TE, Johnson N, Lethaby A, et al.: Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev 2009: CD003677.","DOI":"10.1002\/14651858.CD003677.pub4"},{"key":"10.3238\/arztebl.2014.0877_ref28","doi-asserted-by":"crossref","unstructured":"Kr\u00f6ncke TJ, David M: Uterusarterienembolisation (UAE) zur Myombehandlung; R\u00f6Fo 2013; 185: 461\u20133.","DOI":"10.1055\/s-0033-1335339"},{"key":"10.3238\/arztebl.2014.0877_ref29","doi-asserted-by":"crossref","unstructured":"Gupta JK, Sinha A, Lumsden MA, et al.: Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst Rev 2012; 5: CD005073.","DOI":"10.1002\/14651858.CD005073.pub3"},{"key":"10.3238\/arztebl.2014.0877_ref30","doi-asserted-by":"crossref","unstructured":"Toor SS, Jaberi A, Macdonald DB. Complication rates and effectiveness of uterine artery embolization in the treatment of symptomatic leiomyomas: a systematic review and meta-analysis. AJR 2012; 199: 1153\u201363.","DOI":"10.2214\/AJR.11.8362"},{"key":"10.3238\/arztebl.2014.0877_ref31","doi-asserted-by":"crossref","unstructured":"van der Kooij SM, Shandra Bipat MD, et al.: Uterine artery embolization versus surgery in the treatment of symptomatic fibroids: a systematic review and metaanalysis; Am J Obstet Gynecol 2011; 205: 317, e1\u201318.","DOI":"10.1016\/j.ajog.2011.03.016"},{"key":"10.3238\/arztebl.2014.0877_ref32","doi-asserted-by":"crossref","unstructured":"Froeling V, Meckelburg K, Schreiter NF, et al.: Outcome of uterine artery embolization versus MR-guided high-intensity focused ultrasound treatment for uterine fibroids: Long-term results. Eur J Radiol 2013; 82: 2265\u20139.","DOI":"10.1016\/j.ejrad.2013.08.045"},{"key":"10.3238\/arztebl.2014.0877_ref33","unstructured":"Kamp JE, David M, Scheurig-Muenkler C, Hengst S, Beck A: Clinical outcome of magnetic-resonance-guided focused ultrasound surgery (MRgFUS) in the treatment of symptomatic uterine fibroids. Rofo 2013; 185: 136\u201343."},{"key":"10.3238\/arztebl.2014.0877_ref34","doi-asserted-by":"crossref","unstructured":"Trumm CG, Stahl R, Clevert DA, et al.: Magnetic resonance imaging-guided focused ultrasound treatment of symptomatic uterine fibroids: Impact of technology advancement on ablation volumes in 115 patients. Invest Radiol 2013; 48: 359\u201365.","DOI":"10.1097\/RLI.0b013e3182806904"},{"key":"10.3238\/arztebl.2014.0877_ref35","doi-asserted-by":"crossref","unstructured":"Stang A, Merrill RM, Kuss O. Hysterectomy in Germany: a DRG-based nationwide analysis, 2005\u20132006. Dtsch Arztebl Int 2011; 108: 508\u201314.","DOI":"10.3238\/arztebl.2011.0508"},{"key":"10.3238\/arztebl.2014.0877_ref36","doi-asserted-by":"crossref","unstructured":"Spies JB, Bruno J, Czeyda-Pommersheim F, Magee ST, Ascher SA, Jha RC: Long-term outcome of uterine artery embolization of leiomyomata. Obstet Gynecol 2005, 106: 933\u20139.","DOI":"10.1097\/01.AOG.0000182582.64088.84"},{"key":"10.3238\/arztebl.2014.0877_ref37","doi-asserted-by":"crossref","unstructured":"Goodwin SC, Spies JB, Worthington-Kirsch R, et al.: Uterine artery embolization frp treatment of leiomyoma: long-term outcomes from FIBROID registry. Obstet & Gynecol 2008; 111: 22\u201332.","DOI":"10.1097\/01.AOG.0000296526.71749.c9"},{"key":"10.3238\/arztebl.2014.0877_ref38","doi-asserted-by":"crossref","unstructured":"Stewart EA, Gostout B, Rabinovici J, et al.: Sustained relief of leiomyoma symptoms by using focused ultrasound surgery. Obstet & Gynecol 2007; 110: 279\u201387.","DOI":"10.1097\/01.AOG.0000275283.39475.f6"},{"key":"10.3238\/arztebl.2014.0877_ref39","doi-asserted-by":"crossref","unstructured":"Saccardi C, Conte L, Fabris A, et al.: Hysteroscopic Enucleation in toto of submucous type 2 myomas: Long-term follow-up in women affected by menorrhagia. J Minim Invasive Gynecol 2014; 21: 426\u201330.","DOI":"10.1016\/j.jmig.2013.11.007"},{"key":"10.3238\/arztebl.2014.0877_ref40","doi-asserted-by":"crossref","unstructured":"Hanafi M: Predictors of leiomyoma recurrence after myomectomy. Obstet Gynecol 2005; 105: 877\u201381.","DOI":"10.1097\/01.AOG.0000156298.74317.62"},{"key":"10.3238\/arztebl.2014.0877_ref41","doi-asserted-by":"crossref","unstructured":"Robboy SJ, Bentley RC, Butnor K, Anderson MC: Pathology and pathophysiology of uterine smooth-muscle tumors. Environ Health Perspect 2000; 108: 779\u201384.","DOI":"10.1289\/ehp.00108s5779"},{"key":"10.3238\/arztebl.2014.0877_ref42","doi-asserted-by":"crossref","unstructured":"Rein MS, Powell WL, Walters FC, et al.: Cytogenetic abnormalities in uterine myomas are associated with myoma size. Mol Hum Reprod 1998; 4: 83\u20136.","DOI":"10.1093\/molehr\/4.1.83"},{"key":"10.3238\/arztebl.2014.0877_ref43","unstructured":"David M, Kr\u00e4tschell R: Uterusmyome: Korrelation von Befundkenntnisstand und Beschwerden. Frauenarzt 2013; 54: 119\u201323."},{"key":"10.3238\/arztebl.2014.0877_ref44","doi-asserted-by":"crossref","unstructured":"Shokeir TA: Hysteroscopic management in submucous fibroids to improve fertility. Arch Gynecol Obstet 2005; 273: 50\u20134.","DOI":"10.1007\/s00404-005-0729-z"},{"key":"10.3238\/arztebl.2014.0877_ref45","doi-asserted-by":"crossref","unstructured":"Bernard G, Darai E, Poncelet C, Benifla JL, Madelenat P: Fertility after hysteroscopic myomectomy: effect of intramural myomas associated. Eur J Obstet Gynecol Reprod Biol 2000; 88: 85\u201390.","DOI":"10.1016\/S0301-2115(99)00123-2"},{"key":"10.3238\/arztebl.2014.0877_ref46","doi-asserted-by":"crossref","unstructured":"Stewart EA: Uterine fibroids. Lancet 2001; 357: 293\u201398.","DOI":"10.1016\/S0140-6736(00)03622-9"},{"key":"10.3238\/arztebl.2014.0877_ref47","doi-asserted-by":"crossref","unstructured":"Parsanezhad ME, Azmoon M, Alborzi S, et al.: A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status. Fertil Steril 2010; 93: 192\u20138.","DOI":"10.1016\/j.fertnstert.2008.09.064"},{"key":"10.3238\/arztebl.2014.0877_ref48","doi-asserted-by":"crossref","unstructured":"Campo S, Garcea N: Laparoscopic myomectomie in premenopausal women with and without preoperative treatment using gonadotropin-releasing hormone analogues. Human Reprod 1999; 14: 44\u201348.","DOI":"10.1093\/humrep\/14.1.44"},{"key":"10.3238\/arztebl.2014.0877_ref49","doi-asserted-by":"crossref","unstructured":"Felberbaum RE, Germer U, Ludwig M, et al.: Treatment of uterine fibroids with a slow-release formulation of the gonadotrophin releasing hormone antagonist Cetrorelix. Hum Reprod 1998; 13: 1660\u20138.","DOI":"10.1093\/humrep\/13.6.1660"},{"key":"10.3238\/arztebl.2014.0877_ref50","doi-asserted-by":"crossref","unstructured":"Kettel LM, Murphy AA, Morales AJ, Rivier J, Vale W, Yen SS: Rapid regression of uterine leiomyomas in response to daily administration of gonadotropin-releasing hormone antagonist. Fertil Steril 1993; 60: 642\u20136.","DOI":"10.1016\/S0015-0282(16)56214-1"},{"key":"10.3238\/arztebl.2014.0877_ref51","doi-asserted-by":"crossref","unstructured":"Falcone T, Parker WH: Surgical management of leiomyomas for fertility or uterine preservation. Obstet Gynecol 2013; 121: 856\u201368.","DOI":"10.1097\/AOG.0b013e3182888478"},{"key":"10.3238\/arztebl.2014.0877_ref52","doi-asserted-by":"crossref","unstructured":"Ribeiro SC, Reich H, Rosenberg J, Guglielminetti E, Vidali A: Laparoscopic myomectomy and pregnancy outcome in infertile patients. Fertil Steril 1999; 71: 571\u20134.","DOI":"10.1016\/S0015-0282(98)00483-X"},{"key":"10.3238\/arztebl.2014.0877_ref53","doi-asserted-by":"crossref","unstructured":"Miller DA, Goodwin TM, Gherman RB, Paul RH: Intrapartum rupture of the unscarred uterus. Obstet Gynecol 1997; 89: 671\u20133.","DOI":"10.1016\/S0029-7844(97)00073-2"},{"key":"10.3238\/arztebl.2014.0877_ref54","doi-asserted-by":"crossref","unstructured":"Stotland, NE, Lipschitz, LS, Caughey AS: Delivery strategies for women with a previous classic cesarean delivery: adecision analysis. Am J Obstet Gynecol 2002; 187: 1203\u20138.","DOI":"10.1067\/mob.2002.127123"},{"key":"10.3238\/arztebl.2014.0877_ref55","doi-asserted-by":"crossref","unstructured":"Fukuda M, Tanaka T, Kamada M, et al.: Comparison of the perinatal outcomes after laparoscopic myomectomy versus abdominal myomectomy. Gynecol Obstet Invest 2013; 76: 203\u20138.","DOI":"10.1159\/000355098"},{"key":"10.3238\/arztebl.2014.0877_ref56","unstructured":"De Wilde R, Hucke J: Brauchen wir die Uterusarterien-Embolisation? Frauenarzt 2006; 47: 416."},{"key":"10.3238\/arztebl.2014.0877_ref57","unstructured":"Kr\u00f6ncke TJ, David M, Ricke J, et al.: Uterusarterien-Embolisation zur Myombehandlung. Frauenarzt 2006; 47: 412\u201315."},{"key":"10.3238\/arztebl.2014.0877_ref58","doi-asserted-by":"crossref","unstructured":"Mara M, Maskova J, Fucikova Z, Kuzel D, Belsan T, Sosna O: Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovasc Intervent Radiol 2008; 31: 73\u201385.","DOI":"10.1007\/s00270-007-9195-2"},{"key":"10.3238\/arztebl.2014.0877_ref59","doi-asserted-by":"crossref","unstructured":"Pinto I, Chimeno P, Romo A, et al.: Uterine fibroids: uterine artery embolization versus abdominal hysterectomy for treatment\u2014a prospective, randomized, and controlled clinical trial. Radiology 2003; 226: 425\u201331.","DOI":"10.1148\/radiol.2262011716"},{"key":"10.3238\/arztebl.2014.0877_ref60","doi-asserted-by":"crossref","unstructured":"Ruuskanen A, Hippel\u00e4inen M, Sipola P, Manninen H: Uterine artery embolisation versus hysterectomy for leiomyomas: primary and 2-year follow-up results of a randomised prospective clinical trial. Eur Radiol 2010; 20: 2524\u201332.","DOI":"10.1007\/s00330-010-1829-0"},{"key":"10.3238\/arztebl.2014.0877_ref61","doi-asserted-by":"crossref","unstructured":"Kaump GR, Spies JB: The impact of uterine artery embolization on ovarian function. J Vasc Interv Radiol 2013; 24: 459\u201367.","DOI":"10.1016\/j.jvir.2012.12.002"},{"key":"10.3238\/arztebl.2014.0877_ref62","doi-asserted-by":"crossref","unstructured":"Lee MS, Kim MD, Jung DC, et al.: Apparent diffusion coefficient of uterine leiomyoma as a predictor of the potential response to uterine artery embolization. J Vasc Interv Radiol 2013; 24: 1361\u20135.","DOI":"10.1016\/j.jvir.2013.05.054"},{"key":"10.3238\/arztebl.2014.0877_ref63","doi-asserted-by":"crossref","unstructured":"Rabinovici J, David M, Fukunishi H, et al.: Pregnancy outcome after magnetic resonance\u2013guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids. Fertil Steril 2010; 93: 199\u2013209.","DOI":"10.1016\/j.fertnstert.2008.10.001"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2014.0877","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T09:04:41Z","timestamp":1638781481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2014.0877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,22]]},"references-count":63,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2014.0877","relation":{"is-cited-by":[{"id-type":"doi","id":"10.1155\/2016\/2849476","asserted-by":"object"}]},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,22]]}}}